Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2019-08-20 Board/Management Inform…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Nomination committee in Oasmia for the 2019 AGM
Board/Management Information Classification · 99% confidence The document explicitly discusses the composition and representatives of the 'Nomination committee in Oasmia for the 2019 AGM' (Annual General Meeting). It details who constitutes the committee and provides instructions for shareholders wishing to submit proposals for the upcoming AGM. This content directly relates to the preparatory and procedural aspects of the Annual General Meeting, fitting the definition for AGM Information (AGM-R). The document is short and focused on AGM logistics, not a full report or a general regulatory filing.
2019-08-20 English
Valberedning i Oasmia inför årstämma 2019
Board/Management Information Classification · 99% confidence The document is a press release dated August 20, 2019, titled "Valberedning i Oasmia inför årstämma 2019" (Nomination Committee in Oasmia ahead of the 2019 Annual General Meeting). It explicitly discusses the composition of the nomination committee (valberedningen) for the upcoming Annual General Meeting (årsstämma) and provides instructions for shareholders wishing to submit proposals for the next year's AGM. This content directly relates to the procedures and preparatory materials for the Annual General Meeting. Therefore, it fits the definition of AGM Information (AGM-R). The document is short and is a direct announcement regarding the AGM process, not a formal proxy statement (PSI) or voting result (DVA).
2019-08-20 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1696 characters) from Oasmia Pharmaceutical AB regarding the postponement of their Q1 2019/2020 financial report and the scheduling of future reporting dates. It does not contain the financial report itself, but rather serves as a notification of the publication schedule. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2019-08-15 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1696 characters) from Oasmia Pharmaceutical AB regarding the postponement of their Q1 2019/2020 financial report and the scheduling of future reporting dates. It does not contain the financial report itself, but rather serves as a notification of the publication schedule. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2019-08-15 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1696 characters) from Oasmia Pharmaceutical AB regarding the postponement of their Q1 2019/2020 financial report and the scheduling of future reporting dates. It does not contain the financial report itself, but rather serves as a notification of the publication schedule. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2019-08-15 Swedish
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 2,000 characters) from Oasmia Pharmaceutical AB regarding the postponement of their upcoming quarterly report and providing a schedule for future report releases. It does not contain the financial report itself, but rather serves as a notification of the publication timeline. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2019-08-15 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.